Towards a vaccine against Escherichia coli-associated urinary tract infections

Future Microbiology

Volumn 5, Issue 3, 2010, Pages 351-354

  Serino, Laura ^a   Moriel, Danilo Gomes ^a   Rappuoli, Rino ^a   Pizza, Mariagrazia ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CFT 073; CHUA VACCINE; GAMMA INTERFERON; HMA VACCINE; INTERLEUKIN 17; IREA VACCINE; IREN VACCINE; IUTA VACCINE; LHA VACCINE; UNCLASSIFIED DRUG; VACCINE;

BACTERIAL STRAIN; COLONY FORMING UNIT; CYSTITIS; CYTOKINE PRODUCTION; DRUG EFFICACY; ESCHERICHIA COLI; FUNCTIONAL GENOMICS; GENE IDENTIFICATION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IRON TRANSPORT; NONHUMAN; NOTE; PREVALENCE; PRIORITY JOURNAL; PYELONEPHRITIS; UPREGULATION; URINARY TRACT INFECTION;

EID: 77949415399     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.6     Document Type: Note

References (20)

1. Alteri CJ, Hagan EC, Sivick KE, Smith SN, Mobley HL: Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog. 5(9), E1000586 (2009).
2. Hooton TM, Stamm WE: Diagnosis and treatment of uncomplicated urinary tract infection. Infect. Dis. Clin. North Am. 11(3), 551-581 (1997).
3. Hopkins WJ, Elkahwaji J, Beierle LM, Leverson GE, Uehling DT: Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial. J. Urol. 177(4), 1349-1353 (2007).
4. Langermann S, Ballou WR: Development of a recombinant fmch vaccine for urinary tract infections. Adv. Exp. Med. Biol. 539(Pt B), 635-648 (2003).
5. Roberts JA, Kaack MB, Baskin G et al.: Antibody responses and protection from pyelonephritis following vaccination with purifed Escherichia coli PapDG protein. J. Urol. 171(4), 1682-1685 (2004).
6. Hagan EC, Mobley HL: Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect. Immun. 75(8), 3941-3949 (2007).
7. Alteri CJ, Mobley HL: Quantitative profle of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect. Immun. 75(6), 2679-2688 (2007).
8. Hagan EC, Mobley HL: Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol. Microbiol. 71(1), 79-91 (2009).
9. Russo TA, Carlino UB, Johnson JR: Identifcation of a new iron-regulated virulence gene, ireA, in an extraintestinal pathogenic isolate of Escherichia coli. Infect. Immun. 69(10), 6209-6216 (2001).
10. Russo TA, Mcfadden CD, Carlino-Macdonald UB, Beanan JM, Barnard TJ, Johnson JR: IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli. Infect. Immun. 70(12), 7156-7160 (2002).
11. Hancock V, Ferrieres L, Klemm P: The ferric yersiniabactin uptake receptor FyuA is required for effcient bioflm formation by urinary tract infectious Escherichia coli in human urine. Microbiology 154(Pt 1), 167-175 (2008).
12. Russo TA, Mcfadden CD, Carlino-Macdonald UB, Beanan JM, Olson R, Wilding GE: The siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate. Infect. Immun. 71(12), 7164-7169 (2003).
13. Durant L, Metais A, Soulama-Mouze C, Genevard JM, Nassif X, Escaich S: Identifcation of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli. Infect. Immun. 75(4), 1916-1925 (2007).
14. Uehling DT, Wolf L: Enhancement of the bladder defense mechanism by immunization. Invest. Urol. 6(5), 520-526 (1969).
15. Langermann S, Mollby R, Burlein JE et al.: Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J. Infect. Dis. 181(2), 774-778 (2000).
16. O'Hanley P, Lalonde G, Ji G: a-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: effcacy of an a-hemolysin vaccine in preventing renal injury in the Balb/c mouse model of pyelonephritis. Infect. Immun. 59(3), 1153-1161 (1991).
17. Uehling DT, Hopkins WJ, Elkahwaji JE, Schmidt DM, Leverson GE: Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. J. Urol. 170(3), 867-869 (2003).
18. Bauer H W, Alloussi S, Egger G, Blumlein HM, Cozma G, Schulman CC: A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur. Urol. 47(4), 542-548 (2005).
19. Billips BK, Yaggie RE, Cashy JP, Schaeffer AJ, Klumpp DJ: A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. J. Infect. Dis. 200(2), 263-272 (2009).
20. Uehling DT, Hopkins WJ, Jensen J, Balish E: Vaginal immunization against induced cystitis in monkeys. J. Urol. 137(2), 327-329 (1987).